Wednesday, November 4, 2026Updated every morning at 5:30 AM ET
NanotechProgress

Ferumoxytol (Feraheme)

Feraheme is an iron replacement given into a vein to adults with iron deficiency anemia. The iron comes as magnetic iron oxide nanoparticles inside a carbohydrate shell.

DrugBank, ferumoxytol
Iron oxide nanoparticle medicine · how far it has got4/5Approved or on sale

How far from your life: You can get it now, though it may not be common yet.

Independently sourced

From lab to your life

Why it’s on step 4

  1. 1Lab discovery
  2. 2Working prototype
  3. 3Real-world testing
  4. 4Approved or on sale
  5. 5Everyday life

The rule

A regulator approved or cleared it where approval applies (the FDA, the EMA, a CE mark), or it is sold to the public or to customers beyond a trial.

  • AMAG said the FDA had approved Feraheme for all eligible adults with iron deficiency anemia, not only those with kidney disease. Drugs.com approval history
  • The FDA approved Feraheme for iron deficiency anemia in adults with chronic kidney disease. Drugs.com approval history

The short version

What you need to know

Why it matters

Because the particles show up on MRI and stay in the blood a long time, researchers have also examined it as a contrast agent for scans.

DrugBank, ferumoxytol
Is it really nano?

Truly nano

The medicine is the nanoparticles themselves: iron oxide cores in a carbohydrate shell.

DrugBank, ferumoxytol
Where you’ll find it

Given by IV in hospitals and infusion centers to adults with iron deficiency anemia.

US FDA via Drugs.com, 30 Mar 2015
Who’s behind it

Developed by AMAG Pharmaceuticals

On the record

Every step, dated

Newest first. Company-reported means the only source so far is the company itself.

  1. ApprovalCompany-reported

    AMAG said the FDA had approved Feraheme for all eligible adults with iron deficiency anemia, not only those with kidney disease.

    Drugs.com approval history
  2. Approval

    The FDA approved Feraheme for iron deficiency anemia in adults with chronic kidney disease.

    Drugs.com approval history

Is it safe?

What regulators have said

Rulings and reviews from regulators and official scientific panels, oldest first.

  1. Safety

    The FDA added a boxed warning, its strongest kind, because serious and sometimes fatal allergic reactions can occur, and changed the instructions for giving it.

    US FDA via Drugs.com, 30 Mar 2015